Pharma News
-
Vertex announces reimbursement agreement in Australia for ORKAMBI
Pharma | News | 0 Comment | 05 Sep, 2018
Vertex Pharmaceuticals announced the finalization of an agreement with the Australian Government that allows for reimbursement of ORKAMBI (lumacaftor/ivacaftor) for people ages six and...Read more
-
China accepts first application for Humira biosimilar
Pharma | News | 0 Comment | 04 Sep, 2018
Bio-Thera Solutions, a global biopharmaceutical company recently announced that the China National Drug Administration (CNDA) has accepted for review the Biologics License Application (BLA)...Read more
-
Pharma to Market expands into Malaysia
Pharma | News | 0 Comment | 04 Sep, 2018
Pharma To Market, a leading regulatory affairs consulting company operating in the Asia-Pacific region, further expanded their APAC footprint with the establishment of their Mala...Read more
-
Merck bags USFDA approval for 2 new HIV drugs
Pharma | News | 1 Comment | 03 Sep, 2018
Merck recently bagged the U.S. Food and Drug Administration (FDA) approval for two new HIV-1 medicines: DELSTRIGO, a once-daily fixed-dose combination tablet of doravirine (100 mg), lamivud...Read more
-
XingImaging announces Alzheimer's disease PET imaging in Mainland China
Pharma | News | 0 Comment | 03 Sep, 2018
XingImaging LLC, a radiopharmaceutical production and positron emission tomography (PET) acquisition company operating in Mainland China announced that they are using PET Imaging to support...Read more
-
bioLIVE bio processing and manufacturing league table ranks US top
Pharma | News | 0 Comment | 31 Aug, 2018
bioLIVE the new bioprocessing and manufacturing event running alongside this year’s CPhI Worldwide. It announces the initial findings of the world’s first ever biophar...Read more
-
Suven secures product patents in China, Eurasia
Pharma | News | 0 Comment | 31 Aug, 2018
Suven Life Sciences has said that it has been granted a product patent each by China and Eurasia corresponding to a new chemical entity (NCE) for the treatment of disorders associated with ...Read more
-
Jacobio Pharma raises $55 M in series C round
Pharma | News | 0 Comment | 30 Aug, 2018
Qiming Capital and Hillhouse Capital recently led a $55 million series C round in Jacobio Pharmaceuticals, a Beijing-based clinical stage biotech company. Jacobio focuses on the research an...Read more
-
Pharma | News | 0 Comment | 30 Aug, 2018
SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharma by PPF. It will continue to develop the lead program SO-C101&n...Read more
-
Ascletis Appoints Mr. Joshua Zhongbao Ling as VP Finance
Pharma | News | 0 Comment | 30 Aug, 2018
Ascletis Pharma Inc. has announced that Mr. Joshua Zhongbao Ling joined Ascletis as Vice President of Finance. Mr. Ling will be responsible for the corporate finance management. "We are ex...Read more
-
Roche's CEO of the diagnostic division to step down
Pharma | News | 0 Comment | 29 Aug, 2018
Global pharmaceutical and diagnostics giant Roche today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to ...Read more
-
Urovant licenses novel gene therapy for overactive bladder
Pharma | News | 0 Comment | 28 Aug, 2018
Singapore - Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing therapies for urologic conditions, today announced it has licensed a novel investigational gen...Read more
-
Pharmax initiates operations at new Dubai facility
Pharma | News | 0 Comment | 28 Aug, 2018
UAE-based Pharmax Pharmaceuticals has begun production out of its new $34 million facility located in Dubai Science Park. According to the company, the custom-built factory is the first adv...Read more
-
Astellas announces approval of Linzess Tablets in Japan
Pharma | News | 0 Comment | 27 Aug, 2018
Astellas Pharma and Ironwood Pharmaceuticals, recently announced that approval has been obtained in Japan for the guanylate cyclase-C receptor agonist “Linzess Tablets 0.25 mg (g...Read more
-
Mundipharma to launch Cold Defence in Turkey and Canada
Pharma | News | 0 Comment | 27 Aug, 2018
Mundipharma will be introducing Cold Defence™, a new early treatment hailed as a "world-first", in Turkey and Canada to help families stay healthy and fight the co...Read more
-
Shire receives USFDA nod for TAKHZYRO
Pharma | News | 0 Comment | 27 Aug, 2018
Shire, the leading global biotechnology company focused on rare diseases, has announced that following priority review, the U.S. Food and Drug Administration (FDA) has approved TAKHZYRO (la...Read more
-
China Biologic announces updates on unsolicited acquisition proposals
Pharma | News | 0 Comment | 24 Aug, 2018
China Biologic Products Holdings, a leading fully integrated plasma-based biopharmaceutical company in China, announced that the Company's board of directors (the "Board") has received a le...Read more
-
Novartis appoints new CEO for controversial Korean unit
Pharma | News | 0 Comment | 23 Aug, 2018
Singapore- Novartis has appointed the former chief of its Asia Pacific operations, Joshi Venugopal, as interim CEO of its Korea business replacing another interim CEO, Klaus Ribbe, who plan...Read more
